Unlike other treatments that target the vascular system, PT-141 activates melanocortin receptors in the brain, addressing the root cause of low desire
FDA approval normally follows a formal application supported by adequate evidence for a defined product, dose, route, patient population, manufacturing process, labeling, effectiveness, and safety profile
The treatment plan should be reviewed regularly based on results, side effects, and whether continued treatment remains appropriate
I hope this helps everyone understand the excitement of having a genuinely new drug, entirely different to anything weve seen before, especially one that is for menopause
I dive into it a bit below this parenthetical, To understand telomere shortening, first we need to talk about how DNA works cells in your body are constantly dividing to refresh the tissues that they make up
However, given the rapid weight change and potential nutritional impact, it is prudent to monitor linear growth and puberty (height, bone age, sexual maturation) in any pediatric patient on these drugs (38, 42)